Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(18):1359; doi:10.1093/jnci/95.18.1359
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Wang, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wang, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Oxford University Press

NEWS

In Brief

Linda Wang

The first 10% of the full text of this article appears below.

Study Questions Specificity of RNA Interference

RNA interference (RNAi) is gaining attention as a powerful new tool to silence defective genes in certain diseases such as cancer, but a new study suggests that the technique may not be as specific as researchers believe.

The discovery of short interfering RNAs (siRNAs) made RNAi possible in mammalian cells, and it was thought that siRNAs could overcome some of the inherent problems associated with RNAi, such . . . [Full Text of this Article]

Watch and Wait Policy May Be Appropriate for Asymptomatic NHL

Medicare Coverage Encourages Use of Prevention Tests, Study Finds


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?